Solventum Corporation announced the pricing of a secondary offering of 8,800,000 shares of its common stock.
The offering is expected to result in gross proceeds of approximately $648 million to the Selling Shareholder, 3M Company.
The offering is set to close on or about Aug. 15, 2025, pending customary closing conditions.
Offering Details
The secondary offering includes 8,800,000 shares of common stock, with gross proceeds of around $648 million to the Selling Shareholder.
Underwriters
Goldman Sachs & Co. LLC and BofA Securities are acting as the underwriters for the offering.
Regulatory Compliance
The offering is being made under the Company's shelf registration statement on Form S-3, which became effective upon filing with the SEC on Aug. 13, 2025.
- The Offering is a strategic move to generate significant proceeds for the Selling Shareholder, 3M Company.
- Solventum Corporation will not receive any proceeds from the Offering, indicating a direct benefit to the Selling Shareholder.
The announcement of the secondary offering signifies a crucial financial decision for Solventum Corporation and 3M Company, providing insight into their strategic goals and financial objectives.